Dolby Laboratories (DLB) Scheduled to Post Quarterly Earnings on Tuesday
Dolby Laboratories (NYSE:DLB) is scheduled to announce its earnings results after the market closes on Tuesday, January 23rd. Analysts expect the company to announce earnings of $0.54 per share for the quarter. Dolby Laboratories has set its Q1 guidance at $0.55 to $0.61 EPS.
Dolby Laboratories (NYSE:DLB) last announced its earnings results on Wednesday, October 25th. The electronics maker reported $0.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.27 by $0.18. Dolby Laboratories had a return on equity of 10.62% and a net margin of 18.66%. The business had revenue of $242.05 million during the quarter, compared to analyst estimates of $244.80 million. During the same quarter in the previous year, the business earned $0.37 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. On average, analysts expect Dolby Laboratories to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Dolby Laboratories (NYSE DLB) opened at $65.35 on Tuesday. Dolby Laboratories has a 12-month low of $47.19 and a 12-month high of $65.56. The stock has a market capitalization of $6,684.52, a P/E ratio of 33.69, a price-to-earnings-growth ratio of 2.43 and a beta of 0.85.
In related news, SVP Steven E. Forshay sold 9,355 shares of the business’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $57.86, for a total value of $541,280.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Bob Borchers sold 116,821 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $61.15, for a total value of $7,143,604.15. The disclosure for this sale can be found here. Insiders sold 544,409 shares of company stock valued at $33,369,495 in the last quarter. 43.74% of the stock is owned by company insiders.
A hedge fund recently raised its stake in Dolby Laboratories stock. The Manufacturers Life Insurance Company increased its holdings in Dolby Laboratories (NYSE:DLB) by 25.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,564 shares of the electronics maker’s stock after buying an additional 725 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Dolby Laboratories were worth $174,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 52.53% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/16/dolby-laboratories-dlb-scheduled-to-post-quarterly-earnings-on-tuesday.html.
About Dolby Laboratories
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.